Better Therapeutics, Inc.
Better Therapeutics, Inc. (BTTX) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · BTTX · as of Mar 31, 2025
Ownership Breakdown
1
Institutional Holders
▲ 1 vs Q4
$1
Total Inst. Value
▲ $1 vs Q4
54.52M
Shares Outstanding
freeFloat 69.83%
3,000
13F Shares Held
▲ 3,000 vs Q4
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
BTTX largest shareholders · institutional ownership
Q1 2025 · SEC 13F
Showing top 1 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
ANCORA ADVISORS, LLC services-health services | 3.0K | 0.78% | 0.78% | $1,000 | May 15, 2025 | NEW |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q1 2025 vs prior quarter
Q1 2025
0
Increased
+0 shares1
New Positions
first time holders0
Decreased
−0 shares0
Sold Out
fully exitedNet shares change (top 50)
+0
+0 / −0
Net new holders
+1
1 new / 0 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
BTTX insider trading · insider activity
Source: SEC Form 4
Insiders have been net buyers of shares recently. Selling may be driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment.
1
Buy transactions
0
Sell transactions
0.00
Buy/Sell ratio
$0M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
PERRY DAVID P Executive Chairman | Feb 9, 2024 | Award | 839,895 | $0.19 | $160.0K | 2.42M | Form 4 ↗ |
PERRY DAVID P Executive Chairman | Jan 9, 2024 | Award | 1,471,453 | $0.17 | $250.0K | 1.58M | Form 4 ↗ |
PERRY DAVID P Executive Chairman | Dec 18, 2023 | Award | 3,750 | — | — | 105.3K | Form 4 ↗ |
Carmona Richard H director | Dec 18, 2023 | Award | 3,750 | — | — | 157.4K | Form 4 ↗ |
LAVIZZO-MOUREY RISA J director | Dec 18, 2023 | Award | 3,750 | — | — | 13.8K | Form 4 ↗ |
Wynholds Kristin Chief Product Officer | Dec 18, 2023 | Award | 25,362 | — | — | 225.6K | Form 4 ↗ |
Parker Geoffrey M. director | Dec 18, 2023 | Award | 3,750 | — | — | 1.03M | Form 4 ↗ |
Armanino Andrew J. director | Dec 18, 2023 | Award | 3,750 | — | — | 17.1K | Form 4 ↗ |
Miller Leslie A. Principal Accounting Officer | Dec 18, 2023 | Award | 3,587 | — | — | 17.9K | Form 4 ↗ |
Granger Elder director | Dec 18, 2023 | Award | 3,750 | — | — | 39.6K | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Better Therapeutics, Inc. (BTTX) is primarily owned by institutional investors, who hold approximately 0.0% of total shares outstanding. Company insiders own approximately 30.17%, while retail and public investors account for the remaining 69.82%.
The largest institutional shareholder of Better Therapeutics, Inc. is ANCORA ADVISORS, LLC, holding approximately 3,000 shares — equal to 0.78% of outstanding shares — as of March 31, 2025.
A total of 1 institutional investors currently hold BTTX stock, with a combined institutional value of approximately $1 as of the most recent 13F filing period.
Frequently asked questions
BTTX ownershipBetter Therapeutics, Inc. (BTTX) is primarily owned by institutional investors, who hold approximately 0.0% of shares. The largest shareholder is ANCORA ADVISORS, LLC with a 0.78% stake. Company insiders hold 30.17%. Data sourced from SEC Form 13F as of March 31, 2025.